ArticleJournal for immunotherapy of cancer2022

Targeting two distinct epitopes on human CD73 with a bispecific antibody improves anticancer activity.

Odd L Gammelgaard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.